Figure 2.

Benefits from human FMT. AD: Alzheimer's disease; AN: Anorexia nervosa; CeD: Celiac disease; CIPO: Chronic intestinal pseudo-obstruction; CMV: Cytomegalovirus; COPD: Chronic obstructive pulmonary disease; COVID-19: Coronavirus disease 2019; DC: Diversion colitis; Ig A: Immunoglobulin A; DIHS: Drug-induced hypersensitivity syndrome; D-LA: D-lactic acidosis; EBV: Epstein–Barr virus; ET: Essential tremor; FMT: Fecal microbiota transplantation; HE: Hepatic encephalopathy; ICI: Immune checkpoint inhibitor; IPEX syndrome: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome; ITP: Immune thrombocytopenia; MODS: Multiple organ dysfunction syndrome; MS: Multiple sclerosis; NAFLD: Non-alcoholic fatty liver disease; PSC: Primary sclerosing cholangitis; SAH: Severe alcoholic hepatitis; SSc: Systemic sclerosis; TKI: Tyrosine kinase inhibitor; TMAU: Trimethylaminuria.